-
There has been enormous controversy regarding the benefit/safety relationship of the COX-2 inhibitors, which were initially introduced in 1999. This is a cautionary tale.
-
Patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery.
-
The FDA has approved a new intravenous antifungal agent.
-
Management of asthma in America remains problematic, with as many as 5,000 deaths annually in recent years.
-
-
La Puma J. Adverse reactions associated with echinacea use. Altern Med Alert 2002;5(9):112.
-
Roizen MF. Folate for the prevention of colon cancer. Altern Med Alert 2002;5(9):101-104.
-
O'Mathuna DP. Human growth hormone to prevent key physiological effects of aging. Altern Med Alert 2002;5(9):104-107.
-
Nardino RJ. Chelation therapy for coronary artery disease. Altern Med Alert 2002;5(9):107-110.
-
La Puma J. Homeopathic immunotherapy and asthma. Altern Med Alert 2002;5(9):111.
